A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

The US Food and Drug Administration (FDA) has approved Vertex Pharmaceuticals’ oral Journavx (suzetrigine) to treat adults ...

A new study finds that offering these patients pain coping skills training (PCST) significantly reduced their suffering and ...

The FDA approves Vertex's non-opioid oral pain signal inhibitor, Journavx, for treating adults with moderate-to-severe acute pain. Shares rise.

Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new review suggests.

Dr K K Pandey Nowadays, as the number of diabetic patients is increasing rapidly due to unhealthy life style, the condition of their feet is also deteriorating at the same pace due to neglect and ...

People undergoing hemodialysis treatment for kidney failure often experience chronic pain related to their condition, but it ...

Unlike opioid medications, which dull the sensation of pain in the brain ... company is continuing to test it in people who have diabetic neuropathy, in which high blood sugar levels damage ...

The following is a summary of “Feasibility of trancutaneous auricular vagus nerve stimulation in Black and Hispanic/Latino people with peripheral neuropathy,” published in the January 2025 issue of ...

The FDA approves suzetrigine, a non-opioid pain medication, offering a safer alternative to opioids for pain management, ...